Needle or Drip?-Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases
Dig Dis Sci
.
2024 Dec 4.
doi: 10.1007/s10620-024-08772-4.
Online ahead of print.
Authors
An Outtier
1
2
,
Marc Ferrante
3
4
Affiliations
1
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.
2
Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Louvain, Belgium.
3
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.
[email protected]
.
4
Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Louvain, Belgium.
[email protected]
.
PMID:
39633231
DOI:
10.1007/s10620-024-08772-4
No abstract available
Publication types
Editorial